首页> 中文期刊> 《河北联合大学学报(医学版)》 >乳酸杆菌活菌胶囊联合抗真菌药物治疗复发性外阴阴道白假丝酵母菌病的临床观察

乳酸杆菌活菌胶囊联合抗真菌药物治疗复发性外阴阴道白假丝酵母菌病的临床观察

         

摘要

Objective To study the lactic acid bacteria living bacterium capsule in diabetic pa-tients with recurrent vulvovaginal candidiasis vaginal role in the treatment of disease.Methods A total of 95 patients with recurrent vulvovaginal candidiasis of diabetic patients according to the mechanical sampling method were randomly divided into two groups,conventional treatment group (47 cases,the conventional fall blood sugar,the antifungal treatment,dingjunsheng treatment group 48 cases,on the basis of conventional treatment combined with lactic acid bacteria living bacterium capsule,observe two groups before and after treatment in patients with clinical symptoms,signs,vaginal discharge was normal and culture change and relapse,and compared with the conventional treatment group.Results After the initial treatment on jun the curative effect of treatment group and control group no differ-ence (P > 0.05),but the prince was born recurrence rate reduced compared with the conventional treatment group (P <0.05).Conclusion Live lactobacillus capsule in the treatment of diabetic pa-tients with recurrent vulvovaginal candidiasis can reduce the recurrence rate,worthy of clinical use.%①目的探讨乳酸杆菌活菌胶囊(定君生)治疗糖尿病患者复发性外阴阴道白假丝酵母菌病(VVC)的效果。②方法将95例患有复发性 VVC 的糖尿患者按机械抽样法随机分为两组,常规治疗组47例,采用常规降血糖、抗真菌综合治疗;定君生治疗组48例,在常规综合治疗基础上加用乳酸杆菌活菌胶囊。观察比较两组患者治疗前后临床症状、体征、阴道分泌物常规及培养变化情况、复发情况。③结果初始治疗结束后定君生治疗组的治疗效果与对照组比较,差异无统计学意义(P >0.05),但定君生治疗组的复发率较常规治疗组降低,差异有统计学意义(P <0.05)。④结论乳酸杆菌活菌胶囊治疗糖尿病患者复发性 VVC 可以减少其复发率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号